Velmani, 2010 - Google Patents
Probiotics as potential therapies in human gastrointestinal healthVelmani, 2010
View PDF- Document ID
- 15280418693886649800
- Author
- Velmani G
- Publication year
External Links
Snippet
Nowadays, the treatment of gastrointestinal disorders with probiotics is a widely used remedy for intestinal complications in humans. This essential sources of microorganisms was originally developed for the treatment of health illness, based on the ability to …
- 230000000529 probiotic 0 title abstract description 104
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23Y—INDEXING SCHEME RELATING TO LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23Y2300/00—Bifidobacterium
- A23Y2300/55—Longum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23Y—INDEXING SCHEME RELATING TO LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23Y2220/00—Lactobacillus
- A23Y2220/73—Rhamnosus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using micro-organisms or enzymes using only micro-organisms of the genus lactobacteriaceae; Yoghurt
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mombelli et al. | The use of probiotics in medical practice | |
O'sullivan et al. | Probiotics: an emerging therapy | |
Kaur et al. | Probiotics: delineation of prophylactic and therapeutic benefits | |
Gupta et al. | Probiotics | |
Gill et al. | Probiotics and human health: a clinical perspective | |
De Vrese et al. | Probiotics and prebiotics: effects on diarrhea | |
AU2012267516B2 (en) | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes | |
Zuccotti et al. | Probiotics in clinical practice: an overview | |
US20200009202A1 (en) | Bacterial composition and its use | |
US11052122B2 (en) | Lactic bacteria and their use in the prevention of diarrhea | |
Hatakka et al. | Probiotics in intestinal and non-intestinal infectious diseases-clinical evidence | |
US20200121740A1 (en) | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes | |
Bansal et al. | Probiotics: from functional foods to pharmaceutical products | |
Vijaya Kumar et al. | Beneficial effects of probiotics and prebiotics on human health | |
Btvv et al. | Probiotics as potential therapies in human gastrointestinal health | |
Quigley | Probiotics in the management of colonic disorders | |
Zerehpoosh et al. | Probiotics and health | |
Velmani | Probiotics as potential therapies in human gastrointestinal health | |
Arvanitidis et al. | Cholecystocolic fistula demonstrated by endoscopic retrograde cholangiopancreatography | |
Sharma et al. | Probiotics: Making a comeback | |
Garssen et al. | Immunomodulation by probiotics: a literature survey | |
Kumar et al. | Probiotics: biotechnology in prolongation of life | |
Mullin | 3 The Role of the Gut Microbiota | |
Block | Modulation of Escherichia coli O157: H7 mediated production of proinflammatory mediators by two species of Lactobacilli in two conditionally immortal colon epithelial cell lines | |
Bruno | The Lactobacillus species |